About

Wise develops gamified OTC and prescription digital therapeutics that are engaging, accessible, and clinically effective.

Leveraging a proprietary engine based on the principles of a cognitive therapy technique called attention bias modification treatment (ABMT), Wise’s digital therapeutics have demonstrated through numerous randomized placebo-controlled clinical trials (RCTs) to have a meaningful impact on biometric and behavioral endpoints associated with stress and anxiety.

Wise develops gamified OTC and prescription digital therapeutics that are engaging, accessible, and clinically effective.

Leveraging a proprietary engine based on the principles of a cognitive therapy technique called attention bias modification treatment (ABMT), Wise’s digital therapeutics have demonstrated through numerous randomized placebo-controlled clinical trials (RCTs) to have a meaningful impact on biometric and behavioral endpoints associated with stress and anxiety.

Mental Well-Being Requires New Thinking to Overcome Barriers to Diagnosis and Treatment

Wise Therapeutics was founded to transform breakthrough science into accessible and engaging digital therapeutics that address pervasive behavioral health challenges. Why?

We are passionate about addressing the global mental health crisis by creating digital therapies that are engaging, accessible, and clinically effective. 

Our Team

Our Team

Raj Amin
Co-Founder and Chief Executive Officer

Raj Amin has 20+ years of executive leadership building tech companies in consumer services & healthcare. Raj founded Teem Ventures, a product development and venture execution service for Fortune 500 companies and incubated companies. Raj was the Co-Founder/Chairman of Mana Health, which was acquired by Comcast. He was also the Co-Founder and CEO of HealthiNation (a leading consumer healthcare video property).

He has also held Product Leadership roles at Avis Budget Group, Scientific-Atlanta, ReplayTV and N2 Broadband. 

Dr. Tracy Dennis-Tiwary
Co-Founder and Chief Science Officer

For the past 20 years, Dr. Dennis-Tiwary has directed an NIH-funded research lab translating cutting-edge clinical science and cognitive neuroscience into digital therapeutics targeting anxiety, stress, and other mental and behavioral health problems. Her work has been widely published in peer-reviewed scientific journals and featured on national and international media outlets. 

Julia Schulhof
VP - Product

With 15+ years of product development and strategy experience on the leading edge of technology and media, honed at companies such as Hearst Digital, The Knot, and Progyny, Julia Schulhof has been a been a trusted strategic advisor to C-level executives, offering company-wide insight around data-led product development decisions.
 

Nayan Ghosh
Director - Commercial Strategy

Nayan Ghosh has spent his career advising investors, developers and manufacturers of emerging healthcare technologies across medtech, pharma, biotech and digital health, with particular focus on market access and commercialization strategy. Nayan has assisted numerous digital therapeutic developers in navigating the market and policy landscape of this burgeoning therapeutic category. Prior to joining Wise, Nayan was Vice President at the leading healthcare-focused consulting firm, Marwood Group.

Venture Development Partner : Teem Ventures

vertical-divider

Teem Ventures is an NYC-based advisory firm specializing in product strategy and new business execution. Teem’s principals have extensive experience as entrepreneurs and operators building technology driven businesses and scaling them to growth.

Press for Personal Zen​

Contact us